Skip to search formSkip to main contentSkip to account menu

Prothrombin Activity Measurement

Known as: Factor II Activity, PTA, Prothrombin Activity 
The determination of the biological activity of prothrombin in a sample.
National Institutes of Health

Related topics

Related topics

5 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium TerminologyClotting factor II assay

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey
Objective: The impact of age on survival after hepatic resection for hepatocellular carcinoma (HCC) has not been thoroughly… 
2012
2012
Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging.
Highly Cited
2009
Highly Cited
2009
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and…
OBJECTIVE To study the blood clotting tests and endothelial function of polycystic ovary syndrome (PCOS) patients and non… 
Highly Cited
2008
Highly Cited
2008
Risk Assessment of Hepatocellular Carcinoma in Chronic Hepatitis C Patients by Transient Elastography
Objective The degree of liver fibrosis is the strongest indicator of risk for hepatocellular carcinoma (HCC) development… 
Highly Cited
2006
Highly Cited
2006
Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein.
Highly Cited
2004
Highly Cited
2004
The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system.
The common prothrombin gene cleavage site mutation 20210G>A is associated with elevated prothrombin levels and thrombosis. The… 
Highly Cited
1994
Highly Cited
1994
Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities. C.A.L.C. Group. Coagulation Abnormalities in Cirrhosis Study Group.
Highly Cited
1987
Highly Cited
1987
Maternally Administered Antenatal Vitamin K1: Effect on Neonatal Prothrombin Activity, Partial Thromboplastin Time, and Intraventricular Hemorrhage
Infants weighing 1500 g or less at birth are susceptible to intraventricular hemorrhage. This may be due in part to low… 
Highly Cited
1969
Highly Cited
1969
Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin.
A large family has been studied, 11 of whose members have half-normal plasma concentrations of biological prothrombin activity… 
Highly Cited
1969
Highly Cited
1969
Intravascular coagulation in the surgical patient: its significance and diagnosis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)